View Grant Opportunity

Method to Extend Research in Time (MERIT) Award Extension Request (Type 4 eSubmission Clinical Trial Optional)

National Institutes of Health

PAR-25-324

HHS-NIH11

General Information

N/a
Est. Program Funding:
September 7, 2028
Closing Date:
N/a
Expected No. of Awards
N/a
Award Ceiling

Opportunity Number:
PAR-25-324

Owning Agency:
HHS-NIH11

Opportunity Category:
Discretionary (D)

Synopsis

The National Cancer Institute (NCI) Method to Extend Research in Time (MERIT) (R37) Award provides extended grant support to Early Stage Investigators (ESIs). By providing such an opportunity for longer term support to ESIs, the NCI intends to offer flexibility and opportunity for creativity and innovation and additional time to successfully launch their careers and to become more established before having to submit renewal applications (NOT-CA-18-037). The objective of the NCI's ESI MERIT Award is to allow eligible investigators the opportunity to obtain up to 7 years of support in two segments:
Response Date Sep 07, 2028 12:00:00 AM EDT
Posting Date Jan 06, 2025 12:00:00 AM EST
Archive Date Oct 13, 2028 12:00:00 AM EDT
Award Ceiling N/a
Award Floor N/a
Cost Sharing No

Eligibility

Eligible Applicants City or township governments, Independent school districts, Others (see text field entitled "Additional Information on Eligibility" for clarification), Private institutions of higher education, Small businesses, County governments, Special district governments, For profit organizations other than small businesses, State governments, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education, Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Additional Info on Eligibility: Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.

Additional Information

Agency Name National Institutes of Health
Link to Additional Information: https://grants.nih.gov/grants/guide/pa-files/PAR-25-324.html
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact: GrantSolutions Help Desk
Phone: 301-402-2541

CFDA Program(s)

  • 93.393: Cancer Cause and Prevention Research
  • 93.394: Cancer Detection and Diagnosis Research
  • 93.395: Cancer Treatment Research
  • 93.396: Cancer Biology Research
  • 93.397: Cancer Centers Support Grants
  • 93.399: Cancer Control
   

Contact Us



Our expert team at GTC 360° Advisors can help develop your grant strategy, recruit partner organizations, write your full proposal, compile and manage your budgets, and help you submit a compelling and compliant proposal on time.

×

Request Grant Writing Assistance from GTC 360° Advisors

Our expert team at GTC 360° Advisors can help develop your grant strategy, recruit partner organizations, write your full proposal, compile and manage your budgets, and help you submit a compelling and compliant proposal on time.